Simulation-trained paramedics to improve patient experience after a newly discovered brain tumor
The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery
This will test whether simulation training for neurosurgical paramedics helps adults with newly discovered brain tumors feel more satisfied with their hospital care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 11 sites (Brest, Brittany Region and 10 other locations) |
| Trial ID | NCT06962215 on ClinicalTrials.gov |
What this trial studies
This multicenter effort compares patient satisfaction in neurosurgery departments where paramedical staff receive simulation-based training in announcing and accompanying patients with a newly discovered brain tumor versus usual care. Participating centers implement simulation sessions for paramedics focused on communication and patient accompaniment. Adult inpatients who are informed of a potentially malignant brain tumor before histology will complete the EORTC IN-PATSAT32 questionnaire at the end of their hospital stay. Results between trained and untrained centers will be compared to see if simulation training improves satisfaction.
Who should consider this trial
Good fit: Adults hospitalized in a neurosurgery department who are newly found to have a (potentially malignant) brain tumor, covered by social security, and able to give informed consent are eligible.
Not a fit: Patients with a prior personal history of cancer or those without family who cannot receive information are excluded and therefore unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, patients could experience clearer communication and higher satisfaction during the difficult period after a brain tumor diagnosis.
How similar studies have performed: Simulation-based communication training has improved clinician communication in other settings, but applying it specifically to paramedics announcing brain tumor diagnoses in neurosurgery is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient over 18 years of age * Patient covered by a social security scheme * Patient signed informed consent form * Patient found to have a brain tumor (potentially malignant, primary or secondary if this is the mode of entry into the disease) * Hospitalization in the Neurosurgery Department at the time of tumor discovery, before the histological diagnosis is announced. Exclusion Criteria: * Patients with a personal history of cancer * Patient without family AND unable to receive information
Where this trial is running
Brest, Brittany Region and 10 other locations
- CHU Brest — Brest, Brittany Region, France (Not_yet_recruiting)
- CHU Amiens — Amiens, France (Not_yet_recruiting)
- CHU Angers — Angers, France (Not_yet_recruiting)
- CHU Bordeaux — Bordeaux, France (Not_yet_recruiting)
- APHM Nord — Marseille, France (Not_yet_recruiting)
- CHU Nantes — Nantes, France (Not_yet_recruiting)
- CHU Nice — Nice, France (Not_yet_recruiting)
- CHU Rouen — Rouen, France (Not_yet_recruiting)
- CHU Saint Etienne — Saint-Etienne, France (Recruiting)
- CHU Strasbourg — Strasbourg, France (Not_yet_recruiting)
- CHU Tours — Tours, France (Not_yet_recruiting)
Study contacts
- Study coordinator: Doriane Gautier
- Email: doriane.gautier@chu-brest.fr
- Phone: +33 229 020 174
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.